Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
SRG · 10-Q filed August 14, 2026

SRG earnings analysis

What we found in SRG's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Seritage’s second-quarter revenue increased to $5 million from $2 million sequentially but was flat year over year, while operating margin remained deeply negative at -160.9% and free cash flow was negative $17 million. EPS improved slightly to -$0.53 from -$0.56 in the prior quarter. The most material issue is that disclosure controls remain ineffective as of June 30, 2026, with remediation still ongoing; the filing provides no quantitative operating guidance.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue rebounded sequentially
Revenue was $5 million, up from $2 million in 2026 Q1 but unchanged from $5 million in 2025 Q2. Gross margin remained 100.0%.
Operating loss rate improved sequentially
Operating margin improved to -160.9% from -1,005.8% in 2026 Q1, but was unchanged from -160.9% in 2025 Q2.
EPS improved slightly sequentially
Diluted EPS was -$0.53, modestly better than -$0.56 in 2026 Q1 but unchanged from -$0.53 in 2025 Q2.
Cash burn remained elevated
Free cash flow was negative $17 million, deteriorating from negative $6 million in 2026 Q1 and matching negative $17 million in 2025 Q2.
Remediation efforts continue
Management stated that the material weaknesses remain unremediated for the six months ended June 30, 2026, although remediation efforts are ongoing.
Management supports reported statements
Management said the unaudited financial statements fairly present the company’s position, results and cash flows despite the control weaknesses.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Material weaknesses remain unresolved
Disclosure controls were concluded to be ineffective as of the period end because of material weaknesses involving the precision of general-ledger and reconciliation reviews and segregation of duties over journal entries. Management said the weaknesses remain unremediated as of June 30, 2026.
Multiple shareholder lawsuits continue
The company is defending 1 securities class action and 3 derivative actions alleging securities-law, fiduciary-duty and governance failures. The complaints seek compensatory damages in an unspecified amount, and management stated the outcomes cannot be predicted with certainty.
No formal risk-factor update
The company stated that there were no material changes to the risk factors in its 2025 Form 10-K. However, the filing continues to identify legal proceedings and internal-control deficiencies as relevant uncertainties, with the securities action filed on July 1, 2024 and derivative actions filed on January 15, January 20 and May 8, 2025.
Control remediation timing is uncertain
The company said remediation requires additional time for controls to be fully implemented, operate for a sufficient period and be tested by management; therefore, the weaknesses cannot yet be considered completely remediated.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $0 Operating expenses $261 Left as operating profit $-161
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$-0.53
Gross margin
100.0%
Operating margin
-160.9%
Guidance

What they said about what is next.

No quantitative revenue or EPS outlook was provided in the 10-Q; the filing refers investors to the 2025 Form 10-K for risk factors and provides no operating guidance.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 15, 2026
Seritage Growth Properties reported a challenging quarter for Q1 2026, with revenues of $4.17 million, down from $6.7 million in Q1 2025. The company registered significant impairment losses totaling $15.2 million,…
10-K · March 31, 2026
Seritage continues to execute a Plan of Sale as its primary strategy, shrinking to a 10-property portfolio (approximately 0.8 million sq. ft. and 156 acres) as of December 31, 2025. Results remain loss-making with Q4…
10-Q · November 14, 2025
Seritage Growth Properties reported Q3 revenue of $4,785,000 (three months ended Sep 30, 2025), up from $3,251,000 a year earlier, and a narrower net loss of $12.4 million (EPS -$0.24) versus a loss of $22.0 million…
10-Q · August 14, 2024
Seritage reported Q2 revenue of $4.216M and a net loss of $101.227M (EPS -$1.82), driven by sizeable impairment charges and lower disposition gains versus prior year. Management continues to execute its Plan of Sale,…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing SRG makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever